Central Line Associated Blood Stream Infections (CLABSI)

0
Pipeline Programs
2
Companies
1
Clinical Trials
1 recruiting
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

1 companies ranked by most advanced pipeline stage

Providence Therapeutics
1 program
Infection Preventionist Led Best Practices RemindersN/A1 trial
Active Trials
NCT07108660RecruitingEst. Dec 2027

Trial Timeline

Clinical trial activity over time

2025
2026
2027
Providence TherapeuticsInfection Preventionist Led Best Practices Reminders

Clinical Trials (1)

NCT07108660Providence TherapeuticsInfection Preventionist Led Best Practices Reminders

Machine Learning Prediction of Possible Central Line Associated Blood Stream Infections and Rate of Reduction

Start: Jul 2025Est. completion: Dec 2027
N/ARecruiting

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

1 actively recruiting trials
2 companies competing in this space